Lithium Use for Suicide Prevention, Revisited

WORTZEL: Michael K. Cooper Professor of Neurocognitive Disease, Director of Neuropsychiatry, Associate Professor in Psychiatry, Neurology, and Physical Medicine and Rehabilitation, and Faculty for the Forensic Psychiatry Fellowship at the University of Colorado, and Director of Neuropsychiatric Services for the Rocky Mountain MIRECC, Aurora, CO

SIMONETTI: Division of Hospital Medicine, University of Colorado School of Medicine, Aurora, CO

OSLIN: Professor of Psychiatry, Vice Chair for Veterans Health Department of Psychiatry, Perelman School of Medicine, Philadelphia, PA and Director VISN 4 Mental Illness Research, Education and Clinical Center, Crescenz VA Medical Center, Philadelphia, PA

HERMES: Associate Professor of Psychiatry, Yale University School of Medicine, New Haven, CT and Director, Psychotropic Drug Safety Initiative, VA Office of Mental Health and Suicide Prevention, VA Connecticut Healthcare System, West Haven, CT

MATARAZZO: Rocky Mountain Mental Illness Research, Education, and Clinical Center, Veterans Health Administration, and Departments of Psychiatry and Physical Medicine & Rehabilitation, University of Colorado School of Medicine Aurora, CO

Supported in part by the Rocky Mountain Mental Illness Research, Education and Clinical Center for Suicide Prevention within the Department of Veterans Affairs. The views expressed are those of the authors and do not necessarily reflect the position or policy of the VA or the US Government.

The authors declare no conflicts of interest.

Please send correspondence to: Hal S. Wortzel, MD, G3-185, 1700 North Wheeling Street, Rocky Mountain Regional VA Medical Center, Aurora, CO 80045 (e-mail: [email protected]).

留言 (0)

沒有登入
gif